Friday, September 30, 2022
HomeWorld NewsSun Pharma Q4 Results Out Now? Is Company In Loss Profit Explained!

Sun Pharma Q4 Results Out Now? Is Company In Loss Profit Explained!




Sun Pharma Q4 Results Out Now? Is Company In Loss Profit Explained! Many investors are trying to make extra income by investing their money in stocks. Some investors make more money than others. In nearly all cases, a novice investor will lose his money if he tries to invest in stocks. They have followed someone’s advice and invested in shares. Later, they suffer huge losses. Recent reports have shown that large companies have experienced a lot of losses on the stock market. Now, such a loss has been taken out and investors have had to experience huge losses.

Sun Pharma Q4 Results Out Now? Is Company In Loss Profit Explained!




Sun Pharma Q4 Results

The Mumbai-based company reported a loss of Rs 227.38 crore in the quarter under review. This compares to a net profit of Rs 848 crore last year. The quarter’s revenue rose 11% to Rs 9368.048 crore, compared to a year earlier. A Bloomberg poll showed that the firm expected to report a profit in the range of Rs. The revenue was expected at Rs. 9,576 crore and 1,707 crores respectively. Sun Pharmaceutical Industries Limited was the name of this company. A large loss was suffered by it because an amount was deducted.

Sun Pharma’s US sales, which account for 31%, increased 5% annually to $389 million. India’s drugmaker saw its sales rise 16% to Rs 3095.60 million. Heavy losses are not something new. Many companies have suffered heavy losses in the past. It returns to normal. It will also happen for this company, but it is not certain when it will return to normal.

Investors were still looking for safety and were taking all their money out of the shares. It seems that there were some who wanted to buy it and others who wanted to sell it. These days, investors are becoming more sophisticated. They will sometimes buy it, while other times they will purchase it. This stock also has been affected in terms of its sale. Certain markets were grown, while others were not. The company spends Rs. 543.30 crores, compared to 557.10 million crores a previous year. EBITDA rose 15% to Rs. 2279.70 crores. We have so many information that we can inform you if any new information is available. Follow this website until then.




RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular